4
Changes in Ownership
Alkermes plc. Filed Acc 0001520262-26-000002
EVP R&D, Chief Medical Officer sold 4,000 shares at $28.00 ($112,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2026-01-02 | Sale 10b5-1 | −4,000 | $28.00 | $112,000 | 61,740 | D: show line 1 in the form |
| Open-market sales · 4,000 sh · avg $28.00 · $112,000 | |||||||
Loading xslF345X05/form4.xml…